| Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity ACI Depelsenaire, SC Meliga, CL McNeilly, FE Pearson, JW Coffey, ... Journal of Investigative Dermatology 134 (9), 2361-2370, 2014 | 95 | 2014 |
| Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells KJR Ingrid M. Leal Rojas, Wai-Hong Mok, Frances E. Pearson, Yoshihito Minoda ... Frontiers in Immunology, 2017 | 91 | 2017 |
| Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice JB Carey, FE Pearson, A Vrdoljak, MG McGrath, AM Crean, PT Walsh, ... PLoS One 6 (7), e22442, 2011 | 81 | 2011 |
| Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice FE Pearson, CL McNeilly, ML Crichton, CA Primiero, SR Yukiko, ... PloS one 8 (7), e67888, 2013 | 78 | 2013 |
| Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses DA Muller, FE Pearson, GJP Fernando, C Agyei-Yeboah, NS Owens, ... Scientific reports 6 (1), 22094, 2016 | 45 | 2016 |
| Potency assays for novel T-cell-inducing vaccines against malaria Arturo Reyes-Sandoval", Frances E Pearson, Stephen Todryk" & Katie ewer A Reyes-Sandoval Curr Opin Mol Ther 11, 72-80, 2009 | 41 | 2009 |
| Activation of human CD141+ and CD1c+ dendritic cells in vivo with combined TLR3 and TLR7/8 ligation FE Pearson, K Chang, Y Minoda, IML Rojas, OL Haigh, G Daraj, ... Immunology and cell biology 96 (4), 390-400, 2018 | 40 | 2018 |
| Induction of CD8+ T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine FE Pearson, C O’Mahony, AC Moore, AVS Hill Vaccine 33 (28), 3248-3255, 2015 | 39 | 2015 |
| Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model YS Lee, LJ O'Brien, CM Walpole, FE Pearson, IM Leal-Rojas, ... Journal for immunotherapy of cancer 9 (3), 2021 | 34 | 2021 |
| Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells KA Masterman, OL Haigh, KM Tullett, IM Leal-Rojas, C Walpole, ... Journal for immunotherapy of cancer 8 (2), 2020 | 31 | 2020 |
| Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1‐specific CD8+ T cells FE Pearson, KM Tullett, IM Leal‐Rojas, OL Haigh, KA Masterman, ... Clinical & translational immunology 9 (6), e1141, 2020 | 28 | 2020 |
| The changing shape of vaccination: improving immune responses through geometrical variations of a microdevice for immunization ML Crichton, DA Muller, ACI Depelsenaire, FE Pearson, J Wei, J Coffey, ... Scientific reports 6 (1), 27217, 2016 | 28 | 2016 |
| Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch FE Pearson, DA Muller, L Roalfe, M Zancolli, D Goldblatt, MAF Kendall Vaccine 33 (48), 6675-6683, 2015 | 21 | 2015 |
| Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses. Sci Rep 2016; 6: 22094 DA Muller, FE Pearson, GJ Fernando, C Agyei-Yeboah, NS Owens, ... | 7 | |
| Abstract B125: Targeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy K Radford, F Pearson, KA Masterman, K Tullett, O Haigh, C Walpole, ... Cancer Immunology Research 7 (2_Supplement), B125-B125, 2019 | 2 | 2019 |
| Vaccination Method Using Microneedle Arrays AC Moore, F Pearson, AVS Hill, AM Crean, C O'Mahony, MG McGrath, ... US Patent App. 13/643,964, 2013 | 2 | 2013 |
| Targeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy KA Masterman, FE Pearson, K Tullett, O Haigh, C Walpole, G Daraj, ... Annals of Oncology 29, x35-x36, 2018 | 1 | 2018 |
| Analyte measurement system MAF Kendall, SJ Wilson, AM Brewer, CJ Macisaac, FE Pearson US Patent App. 17/765,752, 2023 | | 2023 |
| Targeting human CD141 (+) DC using CLEC9A antibodies for cancer immunotherapy F Pearson, KA Masterman, K Tullett, O Haigh, C Walpole, G Daraj, ... European Journal of Immunology 48, 79-79, 2018 | | 2018 |
| Enhanced systemic immunogenicity achieved by co-localising vaccine with Nanopatch-mediated skin damage adjacent to live cells A Depelsenaire, FE Pearson, OL Haigh, MA Kendall | | 2013 |
